Houston, TX, United States of America

Chang-Sok Oh

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Chang-Sok Oh: Innovator in Cellular Imaging and Therapy

Introduction

Chang-Sok Oh is a prominent inventor based in Houston, TX (US). He has made significant contributions to the fields of chemistry and radionuclide imaging. With a total of 4 patents, his work focuses on innovative labeling strategies and methods for cellular imaging and therapy.

Latest Patents

Chang-Sok Oh's latest patents include a groundbreaking invention that provides a new labeling strategy employing compounds that are NSchelates conjugated to a targeting ligand. This targeting ligand is designed to target various disease-related compounds, including tumor angiogenesis and apoptosis targeting ligands. Additionally, his work pertains to kits that utilize these compounds and methods for assessing the pharmacology of agents of interest. Another notable patent relates to compositions, kits, and methods for imaging and therapy involving N-compounds and derivatives.

Career Highlights

Chang-Sok Oh is affiliated with the University of Texas System, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Chang-Sok Oh has collaborated with notable colleagues, including David J Yang and Dong-Fang Yu. Their combined expertise contributes to the advancement of research and development in cellular imaging and therapy.

Conclusion

Chang-Sok Oh's contributions to the fields of chemistry and imaging technology highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical imaging and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…